IPN01195, IPN01195
CLIN-01195-450
Phase 2 small_molecule active
Quick answer
IPN01195, IPN01195 for Advanced Solid Tumour is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Advanced Solid Tumour
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active